Pin Therapeutics
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $22M
Investors
- 12
About Pin Therapeutics
Based in Seoul, South Korea, and founded in 2017, Pin Therapeutics, formerly known as Pin Therapeutics Korea, is a biotechnology company focused on the research and development of novel drugs, intended to destroy disease-causing proteins in the human body. The company has a subsidiary in South San Francisco, US, and operates a lab facility in Gyeonggi-do, South Korea. Pin Therapeutics specializes in the development of TPD (Targeted Protein Degradation) drugs, capable of degrading and eliminating the pathogenic protein cells associated with cancer diseases, using UPS (Ubiquitin-Proteasome system) technology, which otherwise is not possible with traditional small molecule inhibitors. The company’s product offerings include the drugs, PROTAC (PROteolysis-TArgeting Chimera) and Molecular Glue Degrader, which are similar in the working mechanism, but different in their properties as well as its molecular structure. Pin Therapeutics intends to use the February 2022 investment to fuel its research to launch a lead molecular glue program by 2023. The company also intends to get listed on the KOSDAQ in H2, 2024.
Who invested in Pin Therapeutics
12 investors across 2 rounds
See all investors in Pin Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pin Therapeutics
Who invested in Pin Therapeutics?
Pin Therapeutics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pin Therapeutics raised?
Pin Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pin Therapeutics last raise money?
Pin Therapeutics's most recent round on record is a Series B, in Feb 2022.
What does Pin Therapeutics do?
Based in Seoul, South Korea, and founded in 2017, Pin Therapeutics, formerly known as Pin Therapeutics Korea, is a biotechnology company focused on the research and development of novel drugs, intended to destroy disease-causing proteins in the human body.
Where is Pin Therapeutics headquartered?
Pin Therapeutics is headquartered in Seongnam, South Korea.
Which VCs invest in companies like Pin Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Pin Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pin Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.